BR
BRSF.US Brain Scientific Inc
- Market cap
- USD 745.00
- P/E
- -
- P/B
- 0.22x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is BRSF.US undervalued?
Graham numberThe Graham number of Brain Scientific Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Brain Scientific Inc fundamental analysis
No fundamental analysis for Brain Scientific Inc yet.
Brain Scientific Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Brain Scientific Inc
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG) systems; NeuroEEG amplifier and desktop software used to store and analyze data captured from the NeuroCap; and piezoelectric motors. The company is also developing NeuroHub, whi…
Full company profileBrain Scientific Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Brain Scientific Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | - | - | 7.02K | 7.02K | 489B | 544B | 266K | 215K | - |
| Gross Profit | - | - | 5.86K | 5.86K | 102B | 135B | 83.2K | 54.3K | - |
| Operating Income | -50.00 | -90.7K | -86.0K | -86.0K | -970B | -1.83T | -8.66M | -9.61M | - |
| EBITDA | -50.00 | -90.7K | - | -1.29M | -970B | -1.83T | -8.32M | -7.93M | - |
| Net Income | -50.00 | -90.7K | -92.0K | -92.0K | -1.00T | -4.28T | -9.10M | -12.3M | - |
| EPS | 0.00 | -0.78 | -0.01 | -0.63 | -4,435,796 | -13,579,730 | -25 | -13 | - |
| Balance Sheet | |||||||||
| Total Assets | 10.1K | 3.68K | 2.27K | 180K | 291K | 225K | 13.4M | 11.7M | - |
| Total Liabilities | 100.00 | 84.2K | 175K | 234K | 1.19M | 2.23M | 14.1M | 7.43M | - |
| Shareholders' Equity | 9.95K | -80.5K | -173K | -54.0K | -896K | -2.01M | -695K | 4.32M | - |
| Cash & Short-term Investments | 50.00 | 160.00 | 13.00 | 164K | 261K | 68.9K | 785K | 748K | - |
| Total Debt | - | 35.3K | - | 62.5K | 879K | 761K | 10.7M | 2.86M | - |
| Cash Flow | |||||||||
| Operating Cash Flow | - | -38.8K | -874K | -1.11M | -855K | -932K | -5.87M | -5.94M | - |
| Capital Expenditure | - | 1.96K | 1.96K | 1.14K | 1.01K | 30.4K | 58.6K | 33.3K | 0.00 |
| Free Cash Flow | - | -38.8K | -58.1K | -1.11M | -856K | -962K | -5.93M | -5.97M | - |
| Ratios | |||||||||
| ROE | -0.5% | - | - | - | - | - | - | -285.9% | - |
| ROA | -0.5% | -2,468.9% | -4,047.3% | -51.1% | -344,970,790.4% | -1,903,240,779.8% | -68.0% | -105.1% | - |
| Net Profit Margin | - | - | -1,310.1% | -1,310.1% | -205.2% | -787.2% | -3,424.6% | -5,753.0% | - |
| Debt to Equity | - | - | - | - | - | - | - | 0.66x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Brain Scientific Inc dividends
Brain Scientific Inc has not paid dividends in the last 7 fiscal years.
Last stock split: 1:85 on Feb 3, 2023.
Who owns Brain Scientific Inc
- Insiders 29.34%
- Institutions 30.64%
- Public & others 40.02%
- Shares outstanding 1.24M
- Free float 497K
Brain Scientific Inc company profile
- Company name
- Brain Scientific Inc
- Ticker
- BRSF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 11
- Fiscal year end
- December
- Address
- 6700 Professional Parkway, Sarasota, FL, United States, 34240
- Phone
- 917 388 1578
- Website
- brainscientific.com
About Brain Scientific Inc
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally. It offers NeuroCap, a disposable soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional electroencephalography (EEG) systems; NeuroEEG amplifier and desktop software used to store and analyze data captured from the NeuroCap; and piezoelectric motors. The company is also developing NeuroHub, which allow users to access patient and clinical data to evaluate patient conditions remotely. Its NeuroCap and NeuroEEG products can be used for recording EEG in neurology clinics, urban and rural ED's, ICU's, urgent care clinics, nursing homes and assisted living facilities, sports facilities, remote clinical research studies, and other settings. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida.
Brain Scientific Inc management
4- Mr. Hassan KotobCEO & Chairman · born 1965
- Mr. Daniel CloutierChief Revenue Officer & Director · born 1966
- Dr. Mark P. BroderickPresident of Piezo Motion Corp.
- Mr. Kevin WinterfieldVice President of Marketing & Communications